Humacyte, Inc. Common Stock
HUMA •
Sell Closed
Signal type
Sell
Status
Closed
Open Price
$0.81
Closed Price
$0.69
Performance
14.68%
Days Open
26
Signal Setup
Signal Type Sell
Status Closed
Open Date Mar 19, 2026
Open Price $0.81
Stop Loss $1.41
Timespan Day
Trade Outcome
Closed Status Profit
Closed Date Apr 14, 2026
Closed Price $0.69
Performance 14.68%
Days Open 26
Company Profile
Name Humacyte, Inc. Common Stock
Ticker HUMA
Market Cap $324.20M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $0.69
List Date Aug 27, 2021
Description
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.
Website Open Company Website